Developing a vaccine for the 'zombie drug' xylazine
Published
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people.
Full ArticlePublished
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people.
Full ArticleXylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans...